Olanzapine Injection, Powder, Lyophilized, For Solution
Product Images NDC 83854-003

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Olanzapine (NDC 83854-003). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Anthea Pharma Private Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

"image Description" (Carton Label)

"image Description" (Carton Label)
This text is a detailed description of Olanzapine for Injection, intended for intramuscular use only. It includes information on the contents of the injection, reconstitution instructions, storage guidelines, and manufacturer details. The medication comes in a sterile single-dose vial containing 10mg of Olanzapine. It provides guidance on dosage, administration, and the appearance of the solution. The text emphasizes the need to protect the solution from light and provides details on storing the medication before and after reconstitution.*
FDA Label Image

"image Description" (Olanzapine Injection Structure)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.